ERBB2 and breast cancer: In particular, we demonstrate a specific binding of sdAb-HER2-QDs to HER2 expressed on mammary tumour tissue of SKBR3 and BT474 mice, with the emission of more intense signals compared to a commercial antibody labelled with AF (pAb-HER2-AF).